Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-10

Clinical Trial Update: Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.

View source ↗

Summary

Clinical trial NCT04556279 investigating salt taste thresholds in patients with primary hyperaldosteronism before and after treatment has been withdrawn, per sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Hyperaldosteronism; Primary, Hypertension | Status: WITHDRAWN